Pressmeddelanden
Coegin introduces new tailor-made Follicopeptide complementary product - launching early 2026
Coegin Pharma AB ("Coegin" or "the Company") announces that it has finalized the development of a new, tailor-made Follicopeptide complementary product. It is designed to strengt...
REG
MAR
Coegin Pharma enters collaboration with Hårklinikken - expands Follicopeptide® commercialization with a world renowned hair clinic brand
Coegin Pharma AB ("Coegin" or "the Company") has entered a collaboration with Hårklinikken, a global actor in premium, science-driven hair and scalp health, through the signing o...
Coegin Pharma establishes own agile production facility in Denmark - ensuring control, scalability, and cost efficiency for next phase of growth
Coegin Pharma AB ("Coegin" or "the Company") provides a status update about the establishment of its own agile production facility in Denmark. It enables the Company to secure fu...
REG
MAR
Coegin Pharma enters collaboration with Polish distributor Mercapharm - expands Follicopeptide® commercialisation to Poland
Coegin Pharma AB ("Coegin" or "the Company") has entered a distribution agreement with Mercapharm, a fast-growing Polish distributor, through the signing of a limited purchase or...
REG
MAR
Coegin Pharma enters collaboration with Swedish retailer Gents - kicks off next phase of Follicopeptide commercialisation
Coegin Pharma AB ("Coegin" or "the Company") has entered a distribution agreement with the Swedish premium retail company Gents AB through the signing of a first limited purchase...
REG
Coegin Pharma AB (publ) publishes its Interim Report for the second quarter of 2025
Summary of the Interim ReportThe second quarter of 2025 has been defined by intense preparation for one of the most important milestones in Coegin Pharma's history - the upcoming...
Rapporter
Video
Finansiell kalender
Delårsrapport Q3 2025
Delårsrapport
Bokslutskommuniké 2025
Bokslutskommuniké
Om Coegin Pharma
Coegin Pharma är ett svenskt bioteknikföretag som utvecklar banbrytande innovationer för hår och hud.
Webbplats
www.coeginpharma.com
Bransch
Bioteknik
Prenumerera
Få löpande information från Coegin Pharma via e-post.
Handelsinformation
Kurs 5,96 SEK (2025-11-10)
Förändring 47,89% (2024-11-12)